BRIEF-Stellar Biotechnologies and Neovacs expand KLH supply relationship

Wed Apr 1, 2015 2:27am EDT
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

April 1 (Reuters) - Neovacs SA :

* Says expands KLH supply relationship with Stellar Biotechnologies

* Companies sign KLH supply agreement for Neovacs' kinoid clinical trials and initial commercialization

* Companies have entered into an expanded supply agreement to meet Neovacs' requirements for keyhole limpet hemocyanin (KLH) Source text for Eikon: Further company coverage: (Gdynia Newsroom:)